NCT06294210 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kim HG, Cheon EJ, Bai DS, Lee YH, Koo BH
Stress and Heart Rate Variability: A Meta-Analysis and Review of the Literature. Psychiatry Investig. 2018 Mar;15(3):235-245. doi: 10.30773/pi.2017.08.17. Epub 2018 Feb 28.
Lehrer PM, Gevirtz R
Heart rate variability biofeedback: how and why does it work? Front Psychol. 2014 Jul 21;5:756. doi: 10.3389/fpsyg.2014.00756. eCollection 2014.
Passmore J, Evans-Krimme R
The Future of Coaching: A Conceptual Framework for the Coaching Sector From Personal Craft to Scientific Process and the Implications for Practice and Research. Front Psychol. 2021 Nov 10;12:715228. doi: 10.3389/fpsyg.2021.715228. eCollection 2021.
Reeves JJ, Ayers JW, Longhurst CA
Telehealth in the COVID-19 Era: A Balancing Act to Avoid Harm. J Med Internet Res. 2021 Feb 1;23(2):e24785. doi: 10.2196/24785.

Enhancing Wellbeing in Secondary School Students: A 2-Year Prospective Cohort Study on an App-based Approach With Wellness Resources, Coaching Support, and Biofeedback Monitoring

Details for clinical trial NCT06294210

Clinical trial NCT06294210 - References